Leonteq Securities AG’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-23
Closed -$29.4K 1140
2021
Q2
$29.4K Hold
23
﹤0.01% 903
2021
Q1
$25.4K Buy
+23
New +$30.4K ﹤0.01% 860

Other funds holding CDLX

Leonteq Securities AG's CDLX Position: Q3 2021 in Review

Leonteq Securities AG sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 23 shares — an estimated $29.4K sold.

Leonteq Securities AG first reported a position in CDLX in Q1 2021 and held it in 2 quarters. The position peaked at $29.4K in Q2 2021. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • Leonteq Securities AG reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
  • Leonteq Securities AG sold 23 Cardlytics shares in Q3 2021, an estimated $29.4K.
  • Leonteq Securities AG first reported a position in Cardlytics in Q1 2021 and held it in 2 quarters.
  • Leonteq Securities AG's Cardlytics position peaked at $29.4K in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Leonteq Securities AG's 13F filing for Q3 2021, filed 26 Mar 2026.